WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...
This article is based on a poster originally authored by Julia Scherzinger, Daniel Türk, and Fernando Aprile-Garcia from CYTENA GmbH. There is constant pressure to reduce timelines in mammalian cell ...
Discover how early optimization in stable cell line development accelerates timelines and reduces downstream bottlenecks.
Every cell line development (CLD) campaign turns on one decision: which clone will manufacture the therapy? When monoclonal antibodies (mAbs) dominated the pipeline, clone selection often centered on ...
Cell line development plays a key role in the identification of biological targets and commercial manufacturing of biotherapeutics. Despite its importance, the process faces a number of challenges, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results